Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation

Virology
A KarlasJoachim Denner

Abstract

Transplantation of porcine xenografts into human recipients is a realistic option to overcome the growing worldwide shortage of suitable allogeneic organs. However, there remains the risk of infection by porcine endogenous retroviruses (PERVs) that cannot be eliminated like that by other microorganisms by breeding pigs under specified pathogen-free conditions. To reduce the release of PERVs by porcine transplants, a new approach, RNA interference (RNAi), was applied. Here, we show significant reduction of PERV expression by synthetic short interfering RNAs (siRNAs) corresponding to different parts of the viral genes gag, pol, and env. The most inhibitory sequences were selected and expressed as short hairpin RNAs (shRNAs) by a polymerase III vector system leading to persistent suppression of PERV replication. Cells or organs from transgenic pigs producing such shRNAs should increase the safety of xenotransplantation.

References

Mar 1, 1997·Nature Medicine·C PatienceR A Weiss
Feb 3, 1999·Annals of the New York Academy of Sciences·J Denner
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Feb 27, 2001·Journal of Virology·C PatienceR A Weiss
Mar 27, 2001·Transplant International : Official Journal of the European Society for Organ Transplantation·M LossU Martin
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·N J CaplenR A Morgan
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·E BillyW Filipowicz
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 28, 2002·Journal of Virology·Beth A OldmixonClive Patience
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Apr 18, 2002·Genes & Development·Patrick J PaddisonDouglas S Conklin
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guangchao SuiYang Shi
May 1, 2002·Nature Biotechnology·Cynthia P PaulDavid R Engelke
Jun 11, 2002·Methods : a Companion to Methods in Enzymology·Sayda M ElbashirThomas Tuschl
Aug 9, 2002·RNA·Yan Zeng, Bryan R Cullen
Jan 22, 2003·Nature Structural Biology·Michelle A CarmellThomas A Rosenquist
Jan 30, 2003·RNA·Paula SteinRichard M Schultz
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Aug 23, 2003·Lancet·David K C Cooper
Sep 6, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Markus IrgangJoachim Denner

❮ Previous
Next ❯

Citations

Mar 29, 2006·Proceedings of the National Academy of Sciences of the United States of America·Michael C GoldingMark E Westhusin
May 16, 2014·Viruses·Magdalena C KimsaUrszula Mazurek
Dec 6, 2007·Genome Biology·Karl J ClarkScott C Fahrenkrug
Mar 5, 2013·Molecules and Cells·Yi-Deun JungHeui-Soo Kim
Aug 8, 2008·Current Opinion in Organ Transplantation·Giada MattiuzzoYasuhiro Takeuchi
May 27, 2009·Current Opinion in Organ Transplantation·Linda Scobie, Yasuhiro Takeuchi
Jan 30, 2007·Reproduction, Fertility, and Development·Gábor VajtaZoltán Macháty
Dec 17, 2009·Reproduction, Fertility, and Development·Charles R LongMichael C Golding
Nov 15, 2015·Xenotransplantation·Joachim Denner
Sep 1, 2015·International Journal of Surgery·Joachim Denner, Nicolas J Mueller
Apr 1, 2008·Transplantation Proceedings·J Denner
Oct 14, 2004·Xenotransplantation·Reto M Baertschiger, Leo H Buhler
Jul 2, 2009·Xenotransplantation·Jagdeece RamsoondarDavid Ayares
Jun 17, 2006·The Journal of Gene Medicine·Mali Ketzinel-GiladEithan Galun
Apr 14, 2012·Xenotransplantation·Marwan SemaanJoachim Denner
Sep 29, 2009·Animal Genetics·W Y JungJ H Lee
May 10, 2015·Virus Research·Elena PlotzkiJoachim Denner
Oct 31, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Magdalena BoksaDaniel Lipiński
May 24, 2005·Pharmacology & Therapeutics·Ray K M Leung, Paul A Whittaker
Sep 13, 2018·Expert Review of Proteomics·Maura Brioschi, Cristina Banfi
Apr 12, 2012·Clinical Microbiology Reviews·Joachim Denner, Ralf R Tönjes
Nov 8, 2007·Reviews in Medical Virology·Derrick LouzRob C Hoeben
Feb 14, 2009·Molecules and Cells·Jae-Won HuhHeui-Soo Kim
Sep 20, 2018·Current Diabetes Reports·Elisabeth KemterEckhard Wolf
Dec 11, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xiao-Hua YuYi Wang
Apr 11, 2020·Advanced Drug Delivery Reviews·Dong NiuGeorge M Church

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.